Skip Navigation


Carcinogenesis Advance Access originally published online on February 17, 2005
Carcinogenesis 2005 26(6):1021-1034; doi:10.1093/carcin/bgi050
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Supplementary Material
Right arrow All Versions of this Article:
26/6/1021    most recent
bgi050v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (8)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Motti, M. L.
Right arrow Articles by Viglietto, G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Motti, M. L.
Right arrow Articles by Viglietto, G.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Carcinogenesis vol.26 no.6 © Oxford University Press 2005; all rights reserved.

Reduced E-cadherin expression contributes to the loss of p27kip1-mediated mechanism of contact inhibition in thyroid anaplastic carcinomas

Maria Letizia Motti 1, 6, Daniela Califano 2, Gustavo Baldassarre 3, Angela Celetti 4, Francesco Merolla 1, Floriana Forzati 1, Maria Napolitano 3, Barbara Tavernise 5, Alfredo Fusco and Giuseppe Viglietto 4, 5, *

1 Dipartimento di Biologia e Patologia Cellulare e Molecolare "L.Califano" Facoltà di Medicina e Chirurgia, Università Federico II, via S. Pansini 5, 80131, Napoli, Italy, 2 Istituto Nazionale Tumori, via M. Semmola, 80131, Napoli, Italy, 3 Divisione di Oncologia Sperimentale 2, CRO National Cancer Institute, Via Pedemontana Occidentale 28, 33081 Aviano, Italy, 4 Istituto di Endocrinologia ed Oncologia Sperimentale del CNR c/o Dipartimento di Biologia e Patologia Cellulare e Molecolare "L.Califano" Facoltà di Medicina e Chirurgia, Università Federico II, via S. Pansini 5, 80131, Napoli, Italy and 5 Laboratorio Oncologia Molecolare III, Dipartimento di Medicina Sperimentale e Clinica, Facoltà di Medicina e Chirurgia, Università "Magna Graecia", Campus Universitario Germaneto, Viale Europa, 88100 Catanzaro, Italy
6 Present address: Dipartimento di Shidi delle Instituzioni e dei Sistemi Territoriali, Università "Parthenope", Via Acton 39, 80100, Napoli, Italy

* To whom correspondence should be addressed. Tel: +39 081 7463054; Fax: +39 081 7463037; Email: viglietto{at}sun.ceos.na.cnr.it

In the present study, we have characterized several human thyroid cancer cell lines of different histotypes for their responsiveness to contact inhibition. We found that cells derived from differentiated carcinoma (TPC-1, WRO) arrest in G1 phase at confluence, whereas cells derived from anaplastic carcinoma (ARO, FRO and FB1) continue to grow after reaching confluence. Furthermore, we provide experimental evidence that the axis, E-cadherin/ß-catenin/p27Kip1, represents an integral part of the regulatory mechanism that controls proliferation at a high cell density, whose disruption may play a key role in determining the clinical behaviour of thyroid cancer. This conclusion derives from the finding that: (i) the expression of p27Kip1 is enhanced at high cell density only in cells responsive to contact inhibition (TPC-1, WRO), but not in contact-inhibition resistant cells (ARO, FRO or FB1 cells); (ii) the increase in p27Kip1 also resulted in increased levels of p27Kip1 bound to cyclin E–Cdk2 complex, a reduction in cyclin E–Cdk2 activity and dephosphorylation of the retinoblastoma protein; (iii) antisense inhibition of p27Kip1 upregulation at high cell density in confluent-sensitive cells completely prevents the confluence-induced growth arrest; (iv) proper expression and/or membrane localization of E-cadherin is observed only in cells responsive to contact inhibition (TPC-1, NPA, WRO) but not in unresponsive cells (ARO, FRO or FB1); (v) disruption of E-cadherin-mediated cell–cell contacts at high cell density induced by an anti-E-cadherin neutralizing antibody, inhibits the induction of p27kip1 and restores proliferation in contact-inhibited cells; (vi) re-expression of E-cadherin into cells unresponsive to contact inhibition (ARO, FB1) induces a p27kip1 expression and growth arrest. In summary, our data indicate that the altered response to contact inhibition exhibited by thyroid anaplastic cancer cells is due to the failure to upregulate p27Kip1 in response to cell–cell interactions.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 Mol. Biol. CellHome page
D. Theard, M. A. Raspe, D. Kalicharan, D. Hoekstra, and S. C.D. van IJzendoorn
Formation of E-Cadherin/{beta}-Catenin-based Adherens Junctions in Hepatocytes Requires Serine-10 in p27(Kip1)
Mol. Biol. Cell, April 1, 2008; 19(4): 1605 - 1613.
[Abstract] [Full Text] [PDF]

Home page
 J Mol EndocrinolHome page
L. Leotoing, M. Manin, D. Monte, S. Baron, Y. Communal, C. Lours, G. Veyssiere, L. Morel, and C. Beaudoin
Crosstalk between androgen receptor and epidermal growth factor receptor-signalling pathways: a molecular switch for epithelial cell differentiation
J. Mol. Endocrinol., August 1, 2007; 39(2): 151 - 162.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Biol. CellHome page
M. Perrais, X. Chen, M. Perez-Moreno, and B. M. Gumbiner
E-Cadherin Homophilic Ligation Inhibits Cell Growth and Epidermal Growth Factor Receptor Signaling Independently of Other Cell Interactions
Mol. Biol. Cell, June 1, 2007; 18(6): 2013 - 2025.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
V. Vasko, A. V. Espinosa, W. Scouten, H. He, H. Auer, S. Liyanarachchi, A. Larin, V. Savchenko, G. L. Francis, A. de la Chapelle, et al.
Gene expression and functional evidence of epithelial-to-mesenchymal transition in papillary thyroid carcinoma invasion
PNAS, February 20, 2007; 104(8): 2803 - 2808.
[Abstract] [Full Text] [PDF]

Home page
 J. Exp. Med.Home page
A. Y. Khakoo, S. Pati, S. A. Anderson, W. Reid, M. F. Elshal, I. I. Rovira, A. T. Nguyen, D. Malide, C. A. Combs, G. Hall, et al.
Human mesenchymal stem cells exert potent antitumorigenic effects in a model of Kaposi's sarcoma
J. Exp. Med., May 15, 2006; 203(5): 1235 - 1247.
[Abstract] [Full Text] [PDF]


Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.